H erpes simplex virus infection of the

Similar documents
Disease caused by herpes simplex virus

Condition: Herpes Simplex Keratitis

Herpetic Eye Disease Jason Duncan, OD, FAAO Diplomate, American Board of Optometry Associate Professor, Southern College of Optometry

Experimental staphylococcic keratitis

Q: (picture of typical dendrite) What is the differential diagnosis and describe this entity? How would you treat and why?

Learning Objectives:

Trifluridine Ophthalmic Solution, 1% Sterile

VIROPTIC Ophthalmic Solution, 1% Sterile (trifluridine ophthalmic solution)

Childhood corneal neovascularization

Chronic Infections by Herpes Simplex Viruses and by the Horse and Cat Herpesviruses

INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998

Clinical Decision making in Infectious Keratitis

(From the Division of Radiology, Department of Medicine of the University of Rochester School of Medicine and Dentistry, Rochester, New York)

New Zealand Data Sheet

Ocular infection of rabbits with a Bedsonia isolated from a patient with Reiter's syndrome

Endothelial lesions of rabbit cornea produced by herpes simplex virus. /. O. Oh

BY N. N. SOODt AND V. J. MARMION- St. Paul's Eye Hospital, Liverpool

Isolation of herpes simplex virus from the cornea in

value as a medium for the in vivo cultivation of different

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

Chemical Names: Prednisolone acetate: 11ß,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate.

Epidemiology of herpes simplex keratitis

TOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%)

D90 (27/10/2005) Final SmPC NL/H/653/01

Viroptic (trifluridine) solution [Monarch Pharmaceuticals, Inc.]

Varicella-Zoster Virus Epithelial Keratitis in Herpes Zoster Ophthalmicus

Conjunctivitis in Cats

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION

Clinical Profile of Herpes Simplex Keratitis

Herpes Zoster Ophtalmicus in a HIV positive patient: A Case Report

NEW ZEALAND DATA SHEET 1. PRODUCT NAME

Histopathology of human superficial herpes simplex keratitis

Innovation In Ophthalmology

PRED-G (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% sterile

Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% (Sterile) Rx only

PAINFUL PAINLESS Contact lens user BOV

NEOSPORIN Ophthalmic Solution Sterile (neomycin and polymyxin B sulfates and gramicidin ophthalmic solution, USP)

Eye infections. Hossain Jabbari, MD, MPH, ID & TM Infectious Diseases Dept., Digestive Diseases Research Institute (DDRI) TUMS

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique

Dr Jo-Anne Pon. Dr Sean Every. 8:30-9:25 WS #70: Eye Essentials for GPs 9:35-10:30 WS #80: Eye Essentials for GPs (Repeated)

Photodynamic therapy for IMMK in horses

What are some common conditions that affect the cornea?

founder of McDonald s Restaurants

Herpes simplex virus infections of the eye and their management with acyclovir

UCSF UC San Francisco Previously Published Works

Eye Care for Animals Micki Armour VMD DACVO THE CORNEA

Differential diagnosis of the red eye. Carol Slight Nurse Practitioner Ophthalmology

New Zealand Data Sheet

Condition: Herpes Zoster Ophthalmicus (HZO)

Ocular herpes simplex

AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION

Neomycin B (R 1 =H, R 2 =CH 2 NH 2 ) Neomycin C (R 1 =CH 2 NH 2, R 2 =H) The chemical structure for the active ingredient Polymyxin B Sulfate is:

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

Alphaherpesvirinae. Simplexvirus (HHV1&2/ HSV1&2) Varicellovirus (HHV3/VZV)

Herpetic keratitis in zinc-deficient rabbits

Koppolu Sreedhar Reddy 1* and Venkata Prasanna DP 2

Laboratory Diagnosis of Endemic

INDICATIONS For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye globe.

Various presentations of herpes simplex retinochoroiditis A case series

CORNEAL DENDRITE. What else do you want to know about this patient? What would be your initial treatment?

THE RED EYE Cynthia McNamara, MD Week 25

OCULAR HERPES simplex virus

D. 'endritic corneal lesions were considered

CONTRAINDICATIONS Active ocular infections (4).

Dr.saifalshamarti. Objective. Where is cornea? Functions of the cornea

INTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.

Definition. Acute inflammation of the conjunctiva due to either viral or bacterial infection

Pathogenesis of viral infection

Case Study: Fuzz April 18th

Clinical Practice Guide for the Diagnosis, Treatment and Management of Anterior Eye Conditions. April 2018

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

a.superficial (adenoid layer).contain lymphoid tissue.

Conjunctivitis in Dogs

Development of chronic conjunctivitis with scarring

Anti-inflammatory effectiveness in the cornea of topically administered prednisolone

APPENDIX 1: SUMMARY OF PRODUCT CHARACTERISTICS. SPC for VEXOL Eye Drops, Suspension 1. NAME OF THE MEDICINAL PRODUCT

however, and the present communication is concerned with some of

The Immune System: The Mind Body Connection. Presented by Margaret Kemeny, Ph.D. Department of Psychiatry, University of California, San Francisco

It has previously been shown that pine

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

Herpes simplex virus (HSV) stromal keratitis is the leading infectious cause of corneal blindness in

Marginal ulceration of the cornea

An outbreak of adenovirus keratoconjunctivitis in Bristol

Systemic immunity in herpetic keratitis

Conjunctivitis in dogs

The side effects of corticosteroids. Bernard Becker

OOGZIEKTEN VOOR DE HUISARTS F. GOES, JR.

Nonulcerative Keratitis (Type of Inflammation of the Cornea) Basics

Nonulcerative Keratitis (Type of Inflammation of the Cornea) Basics

Specialist Referral Service Willows Information Sheets. Recurrent corneal erosions (indolent ulcers)

NEW ZEALAND DATA SHEET

Focusing on A&E. By Sandy Cooper, (Ophthalmic Nurse Practitioner), Tel

Epidemiological and clinical features of primary herpes simplex virus ocular infection

Some strains of these bacteria may be resistant to sulfacetamide or resistant strains may emerge in vivo.

NEW ZEALAND DATA SHEET 1. PRODUCT NAME

CLINICAL PHARMACOLOGY

Transcription:

Herpes simplex keratitis An experimental study Samuel J. Kimura, Victor Diaz-Bonnet, and Masao Okumoto The incidence of complicated herpes simplex keratitis appears to have increased and the important factor seems to be associated with the use of topical corticosteroid hormone. A good experimental model exists for the study of herpetic keratitis. The disease corresponds to the primary infection in man. The unfavorable effects of corticosteroid hormone on experimental herpetic keratitis is reported. H erpes simplex virus infection of the cornea is a serious eye disease, perhaps the most important corneal disease today. A review of the literature seems to indicate that herpetic keratitis has become a major eye problem in the last 15 years, and clinicians who have been in practice for the past 30 years state that they have noted this definite trend. They agree that probably the most significant factor causing this has been the development and use of corticosteroid hormones locally in the eye. They also note that other manifestations of herpes simplex, including labial, visceral, and cutaneous have not changed during this period. Experimental study of herpes simplex keratitis is facilitated by having a good experimental model in the rabbit. The From the Department of Ophthalmology and the Francis I. Proctor Foundation for Research in Ophthalmology, University of California School of Medicine, San Francisco. This investigation was supported in part by Grant-in-Aid No. G-238 from the National Council to Combat Blindness. rabbit is not a natural host for the herpes simplex virus, but when the virus is inoculated into rabbits they develop a primary infection and react similarly to man. The experimental eye disease is an acute keratoconjunctivitis characterized by dendritic keratitis and conjunctivitis. The disease heals completely in 10 to 14 days without treatment. Local corticosteroid treatment of experimental herpetic keratitis can produce all types of complicated herpetic lesions of the cornea such as disciform keratitis, chronic herpetic ulcers, secondary bacterial infections, uveitis, and even corneal perforation. As with any experimental work the interpretation of the results in rabbits is subject to definite limitations. However, the similarity of the herpetic corneal disease in man and rabbits is so striking that the results of the animal experiments are probably quite significant. Experimental herpes simplex keratoconjunctivitis Primary infection. When herpes simplex virus is scratched on the rabbit cornea a 273

274 Kimura, Diaz-Bonnet, and Okumoto Investigative Ophthalmology April 1962 Table I. Similarity of clinical and experimental primary infections with herpes simplex virus 1. The dendritic figure is identical morphologically 2. Epithelial scrapings of the ulcer show giant cells 3. Virus can be cultured from epithelial scrapings 4. Uncomplicated cases run a self-limited course 5. Local corticosteroid therapy makes the infection worse a. Prolongation of course b. Production of uveitis dendritic ulcer usually develops on the scratch in from 24 to 48 hours. There is an associated mild conjunctivitis with a slight mucous discharge. The eye is slightly inflamed, and, on close examination, a dendritic ulcer can be identified. If the virus is inoculated into Tenon's space, the virus then spreads to the cornea, probably by way of the corneal nerves. Many dendritic figures form diffusely over the whole cornea. The disease subsides in 11 to 14 days. In the rabbit it is very similar to the primary keratoconjunctivitis in human beings although in the latter the disease is more serious. Table I summarizes the similarities. Recurrences. There is no experimental model of latent and recurrent herpetic keratitis available in laboratory animals at this time. The only manifestation of herpes simplex virus that has been reactivated experimentally is encephalitis. Schmidt and Rasmussen 1 reported activation of latent herpes simplex encephalitis in rabbits by intramuscular injection of Adrenalin into partially immunized rabbits. In human beings, of course, the recurrent disease is most important since the recurrences of herpetic keratitis result in corneal scarring with loss of vision. Primary herpetic keratoconjunctivitis in rabbits treated with corticosteroids. The treatment of experimental herpetic keratoconjunctivitis with corticosteroids results in a more severe disease with a prolonged course and in many instances the rabbits die of encephalitis. 2 It is not known how the corticosteroids cause this worsening of the disease. We thought that it might be due to an increased multiplication of the virus because corticosteroids have been shown to have this effect on other viruses, such as those of influenza 3 and poliomyelitis.' 1 Jawetz, Okumoto, and Sonne 5 in 1959, however, were not able to show any increased multiplication of the virus in rabbit corneas. This suggested that the effect is not due to suppression of antibody formation by the steroid. We G attempted to demonstrate a change in the mucopolysaccharide or the collagen of the cornea by the corticosteroid drug, but were unsuccessful. Experimental study. The present study was designed to observe the histologic characteristics of herpetic keratitides and test the effect of corticosteroid hormone on experimental keratitis. Methods and materials Animals. Thirty black Dutch rabbits which weighed approximately 4 pounds were obtained from a commercial breeder and 3 series of 10 Table II. Clinical picture of experimental herpetic keratitis Days post inoculation 4 to 5 8 to 9 12 to 13 19 Steroids Keratoconjunctivitis, mild Keratoconjunctivitis, severe Keratoconjunctivitis (disciform), severe Uveitis Chronic keratoconjunctivitis, severe Uveitis Vehicle control Keratitis, slight Keratoconjunctivitis, mild Healed 1 Uveitis Corneas healed 2 Uveitis Saline control Keratitis, slight Keratoconjunctivitis, mild Healed

Volume 1 Ninnber 2- rabbits each were inoculated with virus suspension beneath Tenon's capsule. Virus. The PH ("O") strain of herpes simplex virus was used. The stock virus was prepared by injecting mouse brain and making a 20 per cent suspension of mouse brain in skimmed milk. We injected 0.03 ml. of this virus suspension with an LDtw titer of 1 x 10"5 in each eye, Steroids. Prednisolone acetate (Meticortelone acetate 0 ), 25 mg. per milliliter was used in the first series. Two days prior to the virus injection 0.2 ml. (5 mg.) of the suspension was injected subconjunctivally and it was repeated every other day for the length of the experiment. Steroid vehicle control. The vehicle solution of Meticortelone acetate for the second series was prepared according to the formula issued with each multidose vial (phenylethyl alcohol 5 mg. per milliliter, benzalkonium chloride 0.1 mg. per milliliter, H-X) C.P.). This vehicle solution was injected subconjunctivally (0.2 ml.) into eyes of the control series. Saline. Saline was used in the third series. Rabbits from each series were sacrificed periodically starting from the fourth day post inoculation. Eyes were photographed prior to injecting air into the marginal ear vein. Results Clinical. Table II summarizes the difference in the clinical picture of the corticosteroid-treated rabbits and the controls. The treated animals developed a slight discharge and inflammation of the eyes as early as the second day after the virus was inoculated. By the fourth and fifth days the keratoconjunctivitis was moderately severe. The control rabbits required 6 to 7 days before the keratoconjunctivitis became evident clinically. The eyes of the control animals healed by the twelfth postinoculation day, but the condition in the treated controls persisted through the nineteenth postinoculation day, and all of the rabbits developed uveitis. Two eyes of the vehicle control developed uveitis by the nineteenth postinoculation day. Pathologic. Sections stained with hematoxylin and eosin were studied. Fourth to fifth day post inoculation. Corticosteroid-treated rabbits all developed a moderately severe keratoconjunctivitis. The rabbits inoculated with control fluids 'Schering Corporation, Bloomflcld, N. J. Herpes simplex kemtitis 275 Fig. 1. Corneal epithelium parasitized by herpes simplex virus. Nuclei show intranuclear inclusion bodies. Fig. 2. Histologic section of cornea with herpes simplex keratitis showing a giant cell. Fig. 3. Histologic section of dendritic keratitis treated with corticosteroid hormone. Animal sacrificed 4 days after virus inoculation. developed only a few corneal lesions, and, grossly, the eyes appeared normal. Histologic sections showed typical epithelial lesions of herpes simplex in both the treated and the control series. The epithelial cells bordering the dendritic ulcer showed intranuclear inclusion bodies (Fig. 1) and viral type giant cells (Fig. 2). The

276 Kimura, Diaz-Bonnet, and Okumoto Fig. 4. Histologic section of cornea with herpes simplex keratitis treated with corticosterokl. Investigative Ophthalmology April 1962 clusion bodies were seen by the twelfth day. Giant cells were also not seen in the control animals by the twelfth day. Sixteenth day post inoculation. The eyes of the control animals are completely healed and the sections show a fairly normal picture. The treated eyes still show an active keratoconjunctivitis (Fig. 8). The sections (Fig. 9) show a marked keratitis with edema and necrosis. Nineteenth day post inoculation. The treated eyes remain chronically inflamed (Fig. 10), and, clinically, many of these corneas resembled a chronic herpetic keratitis in man. Inclusion bodies persisted although in diminishing numbers up to the nineteenth day. The cornea showed ex- Fig. 5. Eye of control animal 8 days after virus inoculation. corticosteroid-treated lesions (Fig. 3) showed the presence of inflammatory cells earlier and the stroma showed the presence of edema 3 or 4 days earlier than in the control animals. Along with the edema there were increased numbers of corneal flbrocytes. Eighth to ninth day post inoculation. The corneal lesions were more extensive in the treated animals as compared with the controls. Intranuclear inclusion bodies and giant cells were still present in both series. The stroma of the corticosteroid-treated rabbits showed more extensive infiltration with inflammatory cells (Fig. 4). Fig. 5 is a section of the eye of a control which shows only an epithelial lesion. Twelfth to thirteenth day post inoculation. The treated eye remained actively inflamed with discharge, keratitis, and uveitis (Fig. 6). Fig. 7 shows the presence of inclusion bodies in corticosteroid-treated eyes 13 days after virus inoculation. The corneas of the control animals were completely healed and no intranuclear in- Fig. 6. Corticosteroid-treated experimental herpes.simplex keratitis 13 days after virus inoculation. Fig. 7. Histologic section 13 days after herpes simplex virus inoculation and treated with corticosteroid hormone.

Volume 1 Number 2 Herpes simplex keratitis 277 tensive necrosis of the superficial lamellae (Fig. 11). The picture is certainly similar to the chronic herpetic keratitis that is seen clinically in human beings who have been treated with steroids. The chronic keratitis persisted for several weeks past the nineteenth day and healed with scarring of the cornea. Comment The weight of evidence seems to indicate strongly that corticosteroid hormones have an unfavorable effect on herpes simplex virus infection of the cornea in rabbits. By treating experimental herpetic keratitis with Meticortelone acetate, the course of the keratitis can be prolonged and invariably the eyes develop uveitis. This appears to indicate that the steroid enhances the spread of the virus. Clinically, it is generally accepted that Fig. 10. Corticosteroid-treated eye 19 days after virus inoculation. Fig. 11. Histologic section of rabbit eye treated with corticosteroid hormones for 19 days after virus inoculation. Fig. 8. Corticosteroid-treated rabbit eye 16 days after virus inoculation (keratouveitis). corticosteroid hormones are contraindicated in active herpetic keratitis. Besides the danger of prolonging the course and making the disease more severe, it has been well established that it promotes superinfections by fungi. The mechanism by which steroids affect herpetic keratitis is still unknown. REFERENCES Fig. 9. Histologic section shows marked necrosis of superficial corneal lamellae. Corticosteroidtreated eyes 16 clays after virus inoculation. 1. Schmidt, J. R., and Rasmussen, A. F., Jr.: Activation of latent herpes simplex encephalitis by chemical means, J. Infect. Dis. 106: 154, 1960. 2. Kimura, S. J., and Okumoto, M.: The effect of corticosteroids on experimental herpes simplex keratoconjunctivitis in the rabbit, Am. J. Ophth. 43: (Pt. 2) 131, 1957. 3. Kilbourne, E. D., and Horsfall, F. L., Jr.: Increased virus in eggs injected with cortisone, Proc. Soc. Exper. Biol. & Med. 76: 116, 1961. 4. Teodoru, C. V., and Schwartzman, G.: Endocrine factors in pathogenesis of experimental

278 Kimura, Diaz-Bonnet, and Okumoto Investigative Ophthalmology April 1962 poliomyelitis in hamsters. Role of inoculatory and environmental stress, Proc. Soc. Exper. Biol. & Med. 91: 181, 1956. 5. Javvetz, E., Okumoto, M., and Sonne, M.: Studies on herpes simplex. X. The effects of corticosteroids on herpetic keratitis in the rabbit, J. Immunol. 83: 486, 1959. 6. Kimura, S. J., Diaz-Bonnet, V., Okumoto, M., and Hogan, M.: The effects of corticosteroid hormone on experimental herpes simplex keratitis. A clinical and histopathologic and histochemical study, Am. J. Ophth. 51: (Pt. 2) 945, 1961.